著者

佐々木 英樹 Hideki Sasaki

巻号頁・発行日

no.23, pp.A93-A101, 1990-03-03

著者

佐々木 英樹 Hideki Sasaki

巻号頁・発行日

vol.23, pp.A93-A101, 1990-03-03

著者

Hideki Sasaki Hiroshi Akiyama Yoshifumi Yoshida Kazunari Kondo Yoshiaki Amakura Yoshimasa Kasahara Tamio Maitani

出版者

The Pharmaceutical Society of Japan

雑誌

Biological and Pharmaceutical Bulletin (ISSN:09186158)

巻号頁・発行日

vol.29, no.12, pp.2514-2518, 2006 (Released:2006-12-01)

参考文献数

21

被引用文献数

15 20

---

In autumn 2004, many Japanese patients with renal failure developed cryptogenic encephalopathy by consuming sugihiratake mushroom, a Japanese delicacy. To elucidate the relationship between the cryptogenic cases and this mushroom, we conducted a multivariate analysis of metabolites in ‘Probably Toxic’ sugihiratake collected from the area of encephalopathy outbreaks, and ‘Probably Safe’ sugihiratake collected from unaffected areas using UPLC/ToF MS. The results indicate that the presence of milligram quantities of vitamin D-like compounds per 10 g of dried sugihiratake from the areas of encephalopathy outbreaks. Two hypotheses to induce the encephalopathy are proposed: the found metabolites are (1) vitamin D agonists, which induce acute and severe hypercalcemia and/or hyperammonemia and/or vitamin D toxicity, or (2) vitamin D antagonists, which induce acute and severe hypocalcemia.